Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro.

[1]  Paula M Jacobs,et al.  Preclinical Safety and Pharmacokinetic Profile of Ferumoxtran-10, an Ultrasmall Superparamagnetic Iron Oxide Magnetic Resonance Contrast Agent , 2006, Investigative radiology.

[2]  A. Curtis,et al.  Cell response to dextran-derivatised iron oxide nanoparticles post internalisation. , 2004, Biomaterials.

[3]  Bruno Brochet,et al.  Macrophage Imaging in Central Nervous System and in Carotid Atherosclerotic Plaque Using Ultrasmall Superparamagnetic Iron Oxide in Magnetic Resonance Imaging , 2004, Investigative radiology.

[4]  Heather Kalish,et al.  Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. , 2004, Blood.

[5]  Ernst J. Rummeny,et al.  Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro , 2004, European Radiology.

[6]  Martin J Graves,et al.  In Vivo Detection of Macrophages in Human Carotid Atheroma: Temporal Dependence of Ultrasmall Superparamagnetic Particles of Iron Oxide–Enhanced MRI , 2004, Stroke.

[7]  N. Simpson,et al.  Magnetically labeled insulin-secreting cells. , 2004, Biochemical and biophysical research communications.

[8]  Tilman Grune,et al.  Iron oxide particles for molecular magnetic resonance imaging cause transient oxidative stress in rat macrophages. , 2004, Free radical biology & medicine.

[9]  Matthew J Dalby,et al.  The influence of transferrin stabilised magnetic nanoparticles on human dermal fibroblasts in culture. , 2004, International journal of pharmaceutics.

[10]  Isabelle Raynal,et al.  Macrophage Endocytosis of Superparamagnetic Iron Oxide Nanoparticles: Mechanisms and Comparison of Ferumoxides and Ferumoxtran-10 , 2004, Investigative radiology.

[11]  J. Skepper,et al.  The effect of extracellular tonicity on the anatomy of triad complexes in amphibian skeletal muscle , 2004, Journal of Muscle Research & Cell Motility.

[12]  Heather Kalish,et al.  Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. , 2003, Radiology.

[13]  Jeff W M Bulte,et al.  Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: methods and techniques , 2003, Transplantation.

[14]  Ulrich Heinzmann,et al.  Targeting of hematopoietic progenitor cells with MR contrast agents. , 2003, Radiology.

[15]  Alan P Koretsky,et al.  Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells. , 2003, Blood.

[16]  M. E. Kooi,et al.  Accumulation of Ultrasmall Superparamagnetic Particles of Iron Oxide in Human Atherosclerotic Plaques Can Be Detected by In Vivo Magnetic Resonance Imaging , 2003, Circulation.

[17]  J. Bacri,et al.  Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating. , 2003, Biomaterials.

[18]  J. Debatin,et al.  Magnetic Resonance Imaging of Atherosclerotic Plaque With Ultrasmall Superparamagnetic Particles of Iron Oxide in Hyperlipidemic Rabbits , 2001, Circulation.

[19]  Y Zhang,et al.  Magnetic resonance imaging detection of rat renal transplant rejection by monitoring macrophage infiltration. , 2000, Kidney international.

[20]  Donald S. Williams,et al.  Detection of single mammalian cells by high-resolution magnetic resonance imaging. , 1999, Biophysical journal.

[21]  M. Prince,et al.  Iron oxide‐enhanced MR lymphography: The evaluation of cervical lymph node metastases in head and neck cancer , 1997, Journal of magnetic resonance imaging : JMRI.

[22]  J. Hamers,et al.  [Methods and techniques]. , 1997, Verpleegkunde.

[23]  R. Weissleder,et al.  Cellular Uptake and Trafficking of a Prototypical Magnetic Iron Oxide Label In Vitro , 1995, Investigative radiology.

[24]  P. Jacobs,et al.  Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. , 1995, Magnetic resonance imaging.

[25]  C. W. Jung.  Surface properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. , 1995, Magnetic resonance imaging.

[26]  R. Andres,et al.  Superparamagnetically labelled neutrophils as potential abscess-specific contrast agent for MRI. , 1995, Magnetic resonance imaging.

[27]  F. Wolber,et al.  A simple method for the purification of human peripheral blood monocytes. A substitute for Sepracell-MN. , 1991, Journal of immunological methods.

[28]  R. Weissleder,et al.  Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. , 1990, Radiology.

[29]  R Weissleder,et al.  Superparamagnetic iron oxide: pharmacokinetics and toxicity. , 1989, AJR. American journal of roentgenology.

[30]  W. Fish,et al.  Rapid colorimetric micromethod for the quantitation of complexed iron in biological samples. , 1988, Methods in enzymology.

[31]  G. Rook,et al.  A simple method for the solubilisation of reduced NBT, and its use as a colorimetric assay for activation of human macrophages by gamma-interferon. , 1985, Journal of immunological methods.

[32]  C. Peracchia,et al.  FIXATION BY MEANS OF GLUTARALDEHYDE-HYDROGEN PEROXIDE REACTION PRODUCTS , 1972, The Journal of cell biology.

[33]  M. Karnovsky,et al.  AN ULTRASTRUCTURAL STAINING METHOD FOR ENHANCING THE SIZE AND ELECTRON OPACITY OF FERRITIN IN THIN SECTIONS , 1972, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.